Article

Sara M. Tolaney on Neoadjuvant Treatment Considerations for Triple-Negative Breast Cancer

Author(s):

Sara M. Tolaney, MD, MPH

There are many clinical trial opportunities, Tolaney says, before surgery.

Sara M. Tolaney, medical oncologist, Dana-Farber Cancer Institute, discusses neoadjuvant treatment considerations for patients with triple-negative breast cancer.

“[There are] lots of potential clinical trial opportunities prior to surgery because we do have this question about whether or not platinum therapy is beneficial,” Tolaney says.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of two doctors with text.
Can ctDNA Help Guide Surgical Decision Making in Breast Cancer
Image of doctors with text.
Experts Walk Through Recent Hematologic Malignancy Treatment Updates
Imiage of two doctors with text.
ctDNA-Guided Therapy May Improve Breast Cancer Outcomes
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Zanzalintinib Triplet Combo Under Investigation in Kidney Cancer Subgroups
Image of two doctors and text.
New Treatment Options Emerging for Across Lung Cancer Subtypes
Image of patient and doctor.
Understanding the Whole Person Behind their Cancer Diagnosis
Image of two doctors with text.
Delving Into Brain Cancer Treatment Takeaways Following ASCO 2025
image of gerds
Breaking Down the VERIFY Trial for Patients With Polycythemia Vera
Image of 2 doctors and text.
What Should Patients With Lung Cancer Know After ASCO 2025?
Image of two doctors and text.
Bringing Light to More Personalized Medicine in Lung Cancer After ASCO 2025
Related Content
Advocacy text.
June 19th 2025

Self-Advocacy Can Help Patients Navigate Cancer Treatment Challenges

Mindy Sue Cohen
Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
image of woman.
June 17th 2025

From Navigating the Unknown to Building a Movement: My DCIS Journey

Julia Stalder
The bad news is you have ductal carcinoma in situ. The good news is that DCIS is the best type of breast cancer to get.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
I feel unprepared and overwhelmed after my breast cancer diagnosis, facing treatment like a race, hoping for the strength to reach the finish: © stock.adobe.com
June 15th 2025

Running a Race I Never Chose: Life During Cancer

Avis Yarbrough
I feel unprepared and overwhelmed after my breast cancer diagnosis, facing treatment like a race, hoping for the strength to reach the finish.
Sara Gideon, nurse practitioner, is a compassionate oncology nurse who supports patients with cancer: © stock.adobe.com.
June 15th 2025

Where Compassion Meets Care in Breast Cancer

Margaret Valenti, DNP, RN, AHN-BC, MEDSURG-BC
Sara Gideon, nurse practitioner, is a compassionate oncology nurse who supports patients with cancer, streamlines care and leads with dedication.